Cargando…

Isoproterenol Acts as a Biased Agonist of the Alpha-1A-Adrenoceptor that Selectively Activates the MAPK/ERK Pathway

The α(1A)-AR is thought to couple predominantly to the Gα(q)/PLC pathway and lead to phosphoinositide hydrolysis and calcium mobilization, although certain agonists acting at this receptor have been reported to trigger activation of arachidonic acid formation and MAPK pathways. For several G protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Copik, Alicja. J., Baldys, Aleksander, Nguyen, Khanh, Sahdeo, Sunil, Ho, Hoangdung, Kosaka, Alan, Dietrich, Paul J., Fitch, Bill, Raymond, John R., Ford, Anthony P. D. W., Button, Donald, Milla, Marcos E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301629/ https://www.ncbi.nlm.nih.gov/pubmed/25606852 http://dx.doi.org/10.1371/journal.pone.0115701

Ejemplares similares

Downregulation of β-Adrenoceptors in Isoproterenol-Induced Cardiac Remodeling through HuR
por: Yin, Qian, et al.
Publicado: (2016)

β(2)‐Adrenoceptor agonist activity of higenamine
por: Hudzik, Thomas J., et al.
Publicado: (2021)

Alpha-2 adrenoceptor agonists and sepsis: improved survival?
por: Quintin, Luc
Publicado: (2010)

Paradoxical bronchoconstriction caused by β(2)-adrenoceptor agonists
por: Ayed, Khadija, et al.
Publicado: (2020)

Fingerprinting heterocellular β-adrenoceptor functional expression in the brain using agonist activity profiles
por: Matt, Rachel A., et al.
Publicado: (2023)

Crystal Structures of a Stabilized β(1)-Adrenoceptor Bound to the Biased Agonists Bucindolol and Carvedilol
por: Warne, Tony, et al.
Publicado: (2012)

Structure and Function of an Irreversible Agonist-β(2) Adrenoceptor complex
por: Rosenbaum, Daniel M., et al.
Publicado: (2011)

Functional desensitization of the β(2) adrenoceptor is not dependent on agonist efficacy
por: Rosethorne, Elizabeth M, et al.
Publicado: (2015)

A Selective Pharmacophore Model for β(2)-Adrenoceptor Agonists
por: Xing, Rui-Juan, et al.
Publicado: (2009)

On the Site and Mechanism of Action of β(3)-Adrenoceptor Agonists in the Bladder
por: Andersson, Karl Erik
Publicado: (2017)

The selectivity of α‐adrenoceptor agonists for the human α1A, α1B, and α1D‐adrenoceptors
por: Proudman, Richard G. W., et al.
Publicado: (2021)

Isoproterenol Induces Vascular Oxidative Stress and Endothelial Dysfunction via a Giα-Coupled β(2)-Adrenoceptor Signaling Pathway
por: Davel, Ana P., et al.
Publicado: (2014)

The signaling and selectivity of α‐adrenoceptor agonists for the human α2A, α2B and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
por: Proudman, Richard G. W., et al.
Publicado: (2022)

Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol
por: Beier, Jutta, et al.
Publicado: (2011)

Beta3-Adrenoceptor Agonists: Possible Role in the Treatment of Overactive Bladder
por: Igawa, Yasuhiko, et al.
Publicado: (2010)

Altered uterine contractility in response to β-adrenoceptor agonists in ovarian cancer
por: Modzelewska, Beata, et al.
Publicado: (2016)

Alpha(2)‐adrenoceptor agonists inhibit form‐deprivation myopia in the chick
por: Carr, Brittany J, et al.
Publicado: (2019)

A Clinician’s Perspective on the Mechanism of β(3)-Adrenoceptor Agonists in the Bladder
por: Lee, Tack
Publicado: (2017)

MAPK-ERK Pathway
por: Park, Jong-In
Publicado: (2023)

On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists
por: Pattij, Tommy, et al.
Publicado: (2011)

The long-acting β(2)-adrenoceptor agonist olodaterol attenuates pulmonary inflammation
por: Wex, Eva, et al.
Publicado: (2015)

Dendrobium candidum aqueous extract attenuates isoproterenol-induced cardiac hypertrophy through the ERK signalling pathway
por: Cao, Yuan-Yuan, et al.
Publicado: (2020)

Effects of alpha 2-adrenoceptor agonists dexmedetomidine and guanfacine on morphine analgesia and tolerance in rats
por: Gursoy, Sinan, et al.
Publicado: (2011)

Indacaterol: a new once daily long-acting beta(2) adrenoceptor agonist
por: Beeh, Kai M, et al.
Publicado: (2010)

Reduced suppressive effect of β(2)-adrenoceptor agonist on fibrocyte function in severe asthma
por: Lo, Chun-Yu, et al.
Publicado: (2017)

Selective ß2-Adrenoceptor Agonists and Relevant Hyperlactatemia: Systematic Review and Meta-Analysis
por: Liedtke, Alina G., et al.
Publicado: (2019)

Limited β(2)-adrenoceptor haplotypes display different agonist mediated airway responses in asthmatics
por: van Veen, Anneke, et al.
Publicado: (2006)

Effects of the α(1)-adrenoceptor agonist phenylephrine on SART stress-induced orthostatic hypotension in rats
por: Funakami, Yoshinori, et al.
Publicado: (2010)

Impact of Polymorphic Variants on the Molecular Pharmacology of the Two-Agonist Conformations of the Human β1-Adrenoceptor
por: Baker, Jillian G., et al.
Publicado: (2013)

Rosiglitazone is a superior bronchodilator compared to chloroquine and β-adrenoceptor agonists in mouse lung slices
por: Donovan, Chantal, et al.
Publicado: (2014)

Synthesis and in Vitro and in Vivo Characterization of Highly β(1)-Selective β-Adrenoceptor Partial Agonists
por: Mistry, Shailesh N., et al.
Publicado: (2013)

Scientific rationale for the use of α2A-adrenoceptor agonists in treating neuroinflammatory cognitive disorders
por: Arnsten, Amy F. T., et al.
Publicado: (2023)

ERK/MAPK signalling pathway and tumorigenesis
por: Guo, Yan-Jun, et al.
Publicado: (2020)

Desensitization of cAMP Accumulation via Human β3-Adrenoceptors Expressed in Human Embryonic Kidney Cells by Full, Partial, and Biased Agonists
por: Okeke, Katerina, et al.
Publicado: (2019)

The Novel Mas agonist, CGEN-856S, Attenuates Isoproterenol-Induced Cardiac Remodeling and Myocardial Infarction Injury in Rats
por: Savergnini, Sílvia Q., et al.
Publicado: (2013)

Isoproterenol infusion in septic shock
por: Wiwanitkit, Viroj
Publicado: (2015)

Immunolocalization of Adrenoceptors in the Reproductive Tract of Male Domestic Cats in Comparison to Rats
por: Prochowska, Sylwia, et al.
Publicado: (2021)

Comparative 3D QSAR study on β(1)-, β(2)-, and β(3)-adrenoceptor agonists
por: Senthil Kumar, P., et al.
Publicado: (2009)

The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease()
por: Dale, Philippa R, et al.
Publicado: (2014)

Rosiglitazone and a β(3)-Adrenoceptor Agonist Are Both Required for Functional Browning of White Adipocytes in Culture
por: Merlin, Jon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_55mh66tmk6egtqn5a7e67pijts